HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3,4-methylenedioxy-3',4',5'-trimethoxy chalcone

an anticancer prodrug designed to be activated into a potent tyrosine kinase inhibitor by the tumour selective enzyme activity of the cytochrome P450 enzyme CYP1B1; structure in first source
Also Known As:
DMU-135
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ankrett, Dyan N: 1 article (01/2018)
2. Arroo, Randolph R J: 1 article (01/2018)
3. Beresford, Kenneth J M: 1 article (01/2018)
4. Bhambra, Avninder S: 1 article (01/2018)
5. Butler, Paul C: 1 article (01/2018)
6. Ijaz, Taeeba: 1 article (01/2018)
7. Lodhi, Sabahat: 1 article (01/2018)
8. Potter, Gerard A: 1 article (01/2018)
9. Ruparelia, Ketan C: 1 article (01/2018)
10. Tan, Hoon L: 1 article (01/2018)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Adenoma (Adenomas)

Related Drugs and Biologics

1. Cytochrome P-450 CYP1A1 (CYP1A1)
2. Chalcone (Benzalacetophenone)